slowly slowly ……...
still not sure until they try first in human ?
granted they have a lot of success ... in everything but humans … not sure that makes it 50/50 ?
next year will be the real test ?
potentially it's worth many folds the current value as it always has …
getting expensive from the lab until either somebody is prepared to pay for it or it shows its worth ?
cash in hand is definitely a big plus
Not sure it translates to 14 Q's as the forward estimates though
Unless they plan on staying in the lab for 14Q's ?
Ann: March 2020 Quarterly Activities and Cash Flow Report, page-4
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.020(11.1%) |
Mkt cap ! $933.2M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 20.5¢ | 18.0¢ | $1.219M | 6.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 106194 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 184767 | 1 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |